This Month
Yoga, isolation or a ‘shadow’ board? How economists predict RBA calls
The art of forecasting what the central bank will do with interest rates is a difficult one and, it turns out, everyone has a different approach.
3 ways the tax system is stacked against the young (and 4 fixes)
As the federal government prepares to debate tax reform at a summit next month, we asked experts how to fix one big problem.
Guess who’s unhappy about the surcharge ban? Cafes and retailers
Small business says it will be the “piggy in the middle” as banks and credit card providers won’t lower fees enough to cover the loss of revenue.
Earnings seasons fuelled by AI? Faster, fiercer and more volatile
Surprise results have always taken weeks to be fully appreciated by investors. But a proliferation of new tools is killing the usual post-announcement drift.
Risk is back as investors shrug off Trump and buy up bitcoin, stocks
After retreating to havens like gold and hoarding cash, traders are back in search for bigger returns, sending markets and crypto to records.
Bell Potter trying to escape stockbroking ‘boom and bust’ cycle
The storied markets firm has struck a deal to expand its wealth management services as part of a 15-year strategy to increase and diversify its earnings.
ChatGPT processed 100,000 earnings calls. It has views about analysts
New research suggests a 40 per cent fall in analysts dialling in. In Australia, veterans say it’s down to fewer, more junior, sell-side researchers.
How much would the ASX fall if CBA returned to a ‘normal’ valuation?
Fund managers have steered clear. Analysts are recommending their clients sell. Now MST Marquee has calculated the big hit from a correction in shares.
Markets see signs ‘cost-of-living crisis’ is finally coming to an end
Consumers are “increasingly positive” as household incomes begin to rise and inflation starts to fall, analysts say, in good news for struggling retailers.
June
Tetratherix jumps on debut, capping strong week of ASX listings
The medical device manufacturer has developed a treatment for bone and tissue repair. Shares jumped 7 per cent when they hit the sharemarket on Monday morning.
Stop blaming pandemic for state government debt binge: S&P Global
The high-profile credit ratings agency warns that infrastructure spending and more handouts are causing a significant deterioration in finances.